S4449
Seppro® Neutralization Buffer
Synonym(e):
Tris (hydroxymethyl) aminomethane buffer
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
UNSPSC-Code:
41106500
NACRES:
NA.32
Empfohlene Produkte
Kompatibilität
for use with ABI ViiA 7
Lagertemp.
2-8°C
Allgemeine Beschreibung
Seppro® Neutralization buffer [Tris (hydroxymethyl) aminomethane] is a reagent qualified for use in Seppro® protein preparation and separation systems.
Anwendung
Seppro® neutralization buffer has been used to neutralize the column for immunoglobulin Y (IgY) immunodepletion of top abundant plasma proteins. It has also been used for IgY14 and SuperMix depletion of human plasma.
Rechtliche Hinweise
Seppro is a registered trademark of Merck KGaA, Darmstadt, Germany
Lagerklassenschlüssel
12 - Non Combustible Liquids
WGK
WGK 1
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Persönliche Schutzausrüstung
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Simon Sheng et al.
Methods in molecular biology (Clifton, N.J.), 728, 29-46 (2011-04-07)
Serum- and plasma-based biomarker discovery requires technologies with specific capabilities: sufficient proteome coverage and depth, technical reproducibly, and the scalability to enable analysis on a large number of samples at reasonable cost. We have shown that plasma samples processed using
Majlinda Kullolli et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 939, 10-16 (2013-10-05)
Human plasma is a commonly used diagnostic fluid in clinical chemistry. In-depth plasma proteomic analysis is performed to search for disease biomarkers, however the large dynamic range of protein abundance in plasma presents a substantial analytical challenge. Removal of abundant
Hasmik Keshishian et al.
Nature protocols, 12(8), 1683-1701 (2017-07-28)
Proteomic characterization of blood plasma is of central importance to clinical proteomics and particularly to biomarker discovery studies. The vast dynamic range and high complexity of the plasma proteome have, however, proven to be serious challenges and have often led
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.